DSWISS INC : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K)

ITEM 2.01 Completion of Acquisition or Disposition of Assets.

Acquisition of DSwiss Biotech Sdn Bhd

On March 17, 2016, DSwiss (HK) Limited ("DSHK") invested in DSwiss Biotech Sdn Bhd ("DSBT"), a Company incorporated in Malaysia, and owned 40% of equity interest.

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares (remaining 60% of total number of shares) of DSwiss Biotech Sdn Bhd from a shareholder, Jervey Choon, pursuant to which DSHK acquired 100% of DSBT. As consideration thereof, DSHK agreed to make the proceeds payment of USD 0.23 to the shareholder.

DSwiss Biotech Sdn Bhd primarily operates in Malaysia by supplying biotech products to their clients as set forth below:

Name                                Business Description

DSwiss Biotech Sdn Bhd (Malaysia) Supply biotech products with in-house research

                                    and development. The company mainly focus on
                                    Malaysia clients.

An organizational chart of DSwiss, Inc. is set forth below:

                                [[Image Removed]]

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.                               Description
2.1             Sale and Purchase Agreement, dated as of January 18, 2023, between
              DSwiss (HK) Limited and Jervey Choon
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses